DeepIntent Selected as Exclusive Healthcare DSP for LG Ads Solutions in the U.S.
11-10-2021

Effective immediately, DeepIntent will have exclusive rights as the only DSP healthcare advertisers can use to reach LG Ads Solutions’ 20+ million households nationwide NEW…

Read More
DeepIntent Survey Reveals That Pharmaceutical Advertising Motivates Patients to Research Treatment and Medication Options
10-27-2021

NEW YORK, Oct. 27, 2021 — DeepIntent, the leading independent healthcare marketing technology company built purposefully to influence patient health and business outcomes, today released…

Read More
DeepIntent Named a Company of the Year in PM360 2021 Trailblazer Awards
10-11-2021

NEW YORK, Oct. 11, 2021 — PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has…

Read More
DeepIntent Launches Audience Marketplace
9-27-2021

The release marks the industry’s first and only healthcare-specific data marketplace with ready-to-activate and custom audience segments NEW YORK, Sept. 27, 2021 — DeepIntent, the…

Read More
DeepIntent Awarded Patent for DeepIntent Outcomes™ Technology, Which Optimizes Advertising Campaigns to Increase Script Lift Using Real-World Clinical Data
7-12-2021

With patented technology, the DeepIntent® Demand Side Platform is the first and only proven Demand Side Platform to drive up to 35%* higher…

Read More
DeepIntent Expands Healthcare Marketplace By Integrating Major Supply Sources
5-18-2021

Partners with Magnite, Xandr, Pubmatic, and TripleLift; offers zero-fee trading for direct deals delivering higher yields and greater operational efficiency NEW YORK, May…

Read More
DeepIntent Launches DeepIntent Outcomes™
4-6-2021

Industry’s First Demand-Side Platform Integrated With Real-World Clinical Data to Increase Script Lift, Improving Business Outcomes for Healthcare Marketers Beta leading pharmaceutical brand experienced an…

Read More
DeepIntent Releases Consumer Survey Findings on Impact of Direct-to-Consumer Pharmaceutical Advertising
3-25-2021

Demonstrates gap between patients and providers about treatment options NEW YORK, March 25, 2021 – DeepIntent, the leading healthcare marketing technology company built purposefully to…

Read More
DeepIntent CEO Chris Paquette Named to the MM+M 40 Under 40 Class of 2021
2-22-2021

Paquette honored amongst the brightest young stars in the evolving and expanding realm of healthcare marketing NEW YORK, February 22, 2021 – DeepIntent, the leading…

Read More